10-K/A: Streamline Health Solutions Amends Annual Report, Details Executive Compensation and Governance Amid Missed Bonus Targets

Streamline Health Solutions, Inc. has filed an amendment to its annual report, providing comprehensive details on corporate governance, executive compensation, and director appointments, while disclosing that named executive officers did not receive cash bonuses for fiscal year 2024 due to not meeting adjusted EBITDA targets.

Summary

• Streamline Health Solutions, Inc. filed an Amendment No. 2 to its Annual Report on Form 10-K for the fiscal year ended January 31, 2025, primarily to include information required by Items 10 through 14 of Part III.
• The amendment details the company's corporate governance practices, including the composition and functions of its Audit, Compensation, and Governance and Nominating Committees.
• Executive compensation for fiscal year 2024 included base salaries, long-term equity incentives (restricted stock awards), but no cash bonuses for named executive officers as the company did not exceed its adjusted EBITDA target of $1,700,000.
• Key executive officers and their fiscal year 2024 total compensation were: Wyche T. Tee Green, III (Executive Chairman) at $319,184; Benjamin L. Stilwill (Chief Executive Officer) at $429,212; and Bryant J. Reeves, III (Chief Financial Officer) at $266,949.
• The company's independent registered public accounting firm, Forvis Mazars, LLP, billed $762,944 in total fees for fiscal year 2024, an increase from $663,857 in fiscal year 2023.
• As of April 28, 2025, the number of shares outstanding of the company's Common Stock was 4,331,315, with an aggregate market value of voting and non-voting common stock held by non-affiliates at $23,470,199 as of July 31, 2024.
• The company reported 343,597 shares available for issuance under its 2024 Omnibus Incentive Compensation Plan as of May 12, 2025.

Sentiment

Score: 5

Explanation: The document is primarily an administrative amendment detailing corporate governance and compensation. While it highlights a missed financial target for executive bonuses, which is negative, it also showcases robust governance structures and a commitment to pay-for-performance. The overall sentiment is neutral as the information is largely procedural and backward-looking, without significant new financial or operational updates that would drastically alter the company's outlook.

Positives

• The company is in compliance with current corporate governance requirements imposed by SEC rules and Nasdaq listing standards.
• The roles of Chairman of the board of directors and Chief Executive Officer are separated, allowing the CEO to focus on day-to-day operations and the Chairman to lead board oversight.
• The Audit, Compensation, and Governance and Nominating Committees are comprised entirely of independent directors, enhancing oversight and accountability.
• Jonathan R. Phillips, a member of the Audit Committee, has been determined to be an audit committee financial expert.
• The company's executive compensation program is designed with a 'pay-for-performance' philosophy, aiming to align executive interests with stockholder value through variable compensation components.
• Stockholders demonstrated strong support for the executive compensation program, with over 92% of votes cast in favor of the advisory vote at the 2024 Annual Meeting.
• The company offers a comprehensive package of employee retirement and welfare benefits, including a 401(k) Plan with a company match, available to all eligible associates.
• The company has a comprehensive insider trading policy and does not extend loans to executive officers or directors.

Negatives

• Named executive officers did not receive cash bonuses for fiscal year 2024 because the company did not meet its adjusted EBITDA target of $1,700,000.
• Several Section 16(a) reports were filed late by executive officers (Mr. Green, Mr. Stilwill, Mr. Reeves, Ms. Lovvorn) and directors (Mr. Phillips, Mr. Ferayorni) regarding the surrender of common stock upon vesting of restricted stock to satisfy tax withholding obligations or issuance/disposition of stock.

Risks

• Failure to achieve pre-established financial targets, such as adjusted EBITDA, directly impacts executive incentive compensation, potentially affecting executive motivation and retention.
• The potential for future dilution of grantee interest in the company is acknowledged in restricted stock and RSU agreements, as no adjustments are made for dividends or distributions unless specifically provided.
• Unvested equity awards (restricted stock, RSUs, options) are subject to immediate forfeiture upon termination of service for any reason, and prior vesting/settlement can be rescinded in cases of termination for cause.
• Compliance risks related to timely filing of Section 16(a) reports, as evidenced by multiple late filings by executive officers and directors.

Future Outlook

For the fiscal year ending January 31, 2026, the Compensation Committee plans to consider multiple performance criteria for executive cash bonuses, including bookings, sales, adjusted EBITDA, and the successful completion of certain strategic objectives. The board of directors will also continue to periodically review the company's leadership structure.

Management Comments

• "The Compensation Committee has a conservative pay-for-performance compensation philosophy and aims to have executive compensation practices that align executive pay with Company performance."
• "The Compensation Committee believes any incentive bonuses awarded should demonstrate strong alignment between executive pay and Company performance."
• "The Compensation Committee intends to continually monitor the use of restricted stock as it relates to tax and accounting regulations, overall effectiveness of the programs and best practices."
• "The Company believes a significant portion of a named executive officer’s compensation should be variable, based on the performance of the Company, in order to align our executives’ interests with the interests of our stockholders."
• "The Compensation Committee believes that its fiscal year 2024 approach to awarding long-term incentive compensation provided the appropriate long-term incentives from both executive retention and pay-for-performance perspectives and rewarded such executives for managing through the novel coronavirus pandemic."
• "The Compensation Committee believes that the variable components of compensation are sufficient to motivate named executive officers to produce short-term and long-term Company results, while the fixed element is also sufficient such that executives are not encouraged to take unnecessary or excessive risks in doing so."

Industry Context

Streamline Health Solutions operates within the highly competitive healthcare technology and software-as-a-service (SaaS) industry. The company's compensation practices are benchmarked against a peer group of similarly-sized companies in this sector, reflecting the need to attract and retain talent in a dynamic market. The focus on adjusted EBITDA as a performance metric is common in the software industry for evaluating operational profitability.

Comparison to Industry Standards

• The Compensation Committee utilizes a peer group of 13 similarly-sized healthcare technology and software-as-a-service companies to benchmark executive and non-employee director compensation practices.
• The Compensation Peer Group includes: American Software, Inc., Optimize-Rx Corporation, BSQUARE Corporation, PaySign, Inc., CareCloud, Inc., Phreesia, Inc., Computer Programs and Systems, Inc., RCM Technologies, Inc., Model N, Inc., Verb Technology Company, Inc., National Research Corporation, Vocera Communications, Inc., and Nxt-ID, Inc.
• The company's compensation philosophy emphasizes a significant portion of variable compensation tied to company performance, a common practice in the technology sector to align executive incentives with shareholder value.

Management Changes

Corporate Governance

Related Party Transactions

• No related party transactions requiring disclosure under Item 404 of Regulation S-K were reported for the fiscal year ended January 31, 2025.
• The company has a Master Services Agreement with 180 Consulting, LLC, which provides various services including product management and software engineering. Individuals providing services under this agreement may share workspace and administrative costs with an entity affiliated with Mr. Green.
• Statements of work under the MSA include a sublicense of software through 180 Consulting that is owned by 121G (an entity affiliated with Mr. Green). This arrangement is structured to ensure no material financial benefit accrues to 121G, as 180 Consulting licenses the software at cost.

Stakeholder Impact

• Shareholders: Directly impacted by the company's financial performance (missed EBITDA target), executive compensation structure, and the overall corporate governance framework designed to protect their interests.
• Executive Officers: Their compensation, particularly cash bonuses, is directly tied to the company's financial performance, and their equity awards are subject to vesting schedules and potential forfeiture.
• Employees: Benefit from a comprehensive retirement and welfare benefits package, including a 401(k) plan with company matching contributions, and are subject to the company's Code of Conduct and insider trading policy.
• Auditors: Forvis Mazars, LLP, continues as the independent registered public accounting firm, with increased fees for audit and other services in FY2024, indicating ongoing engagement and oversight.

Next Steps

• The Compensation Committee will consider multiple performance criteria, including bookings, sales, and adjusted EBITDA, for cash bonuses for the fiscal year ending January 31, 2026.
• The Compensation Committee will continue to monitor the use of restricted stock in relation to tax and accounting regulations, program effectiveness, and best practices.
• The board of directors and Governance and Nominating Committee will periodically assess the board leadership structure (separation of Chairman and CEO roles) to ensure optimal service to the company and stockholders.

Key Dates

Recommendation

Keywords

Streamline Health Solutions, SEC filing, 10-K/A, corporate governance, executive compensation, restricted stock, stock options, adjusted EBITDA, healthcare technology, NASDAQ, board of directors, audit committee, compensation committee, insider trading policy